Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 6:13 pm Purchase | 2022-12-31 | 13G | Pyxis Oncology, Inc. PYXS | BIOTECHNOLOGY VALUE FUND L P | 2,938,851 8.400% | 1,147,500 (+64.06%) | Filing History |
| 2023-02-13 5:14 pm Purchase | 2022-12-31 | 13G | Pyxis Oncology, Inc. PYXS | PFIZER INC PFE | 5,221,176 14.880% | 2,229,654 (+74.53%) | Filing History |
| 2023-02-08 5:14 pm Purchase | 2022-12-31 | 13G | Pyxis Oncology, Inc. PYXS | Laurion Capital Management LP | 3,170,803 9.000% | 3,170,803 (New Position) | Filing History |
| 2022-11-04 4:00 pm Purchase | 2022-10-25 | 13G | Pyxis Oncology, Inc. PYXS | TANG CAPITAL PARTNERS LP | 1,981,426 5.600% | 1,981,426 (New Position) | Filing History |
| 2022-05-23 06:15 am Purchase | 2022-03-31 | 13D | Pyxis Oncology, Inc. PYXS | Lara Sullivan, M.D. | 3,466,895 9.600% | 3,466,895 (New Position) | Filing History |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | Pyxis Oncology, Inc. PYXS | RA Capital Management, L.P. | 2,282,173 7.000% | 367,239 (+19.18%) | Filing History |
| 2022-02-14 08:51 am Purchase | 2021-12-31 | 13G | Pyxis Oncology, Inc. PYXS | RTW Investments, LP | 2,120,760 6.500% | 2,120,760 (New Position) | Filing History |
| 2022-02-11 4:35 pm Purchase | 2021-12-31 | 13G | Pyxis Oncology, Inc. PYXS | Bayer World Investments B.V. | 2,742,338 8.400% | 2,742,338 (New Position) | Filing History |
| 2022-02-11 4:26 pm Purchase | 2021-12-31 | 13G | Pyxis Oncology, Inc. PYXS | PFIZER INC PFE | 2,991,522 9.130% | 2,991,522 (New Position) | Filing History |
| 2021-12-20 5:23 pm Purchase | 2021-12-10 | 13G | Pyxis Oncology, Inc. PYXS | BIOTECHNOLOGY VALUE FUND L P | 1,791,351 5.500% | 1,791,351 (New Position) | Filing History |
| 2021-10-25 4:34 pm Purchase | 2021-10-13 | 13G | Pyxis Oncology, Inc. PYXS | RA Capital Management, L.P. | 1,914,934 5.800% | 1,914,934 (New Position) | Filing History |
| 2021-10-21 6:52 pm Purchase | 2021-10-13 | 13D | Pyxis Oncology, Inc. PYXS | Lara Sullivan, M.D. | 2,313,364 6.660% | 2,313,364 (New Position) | Filing History |